Related Experiment Videos
Olanzapine interactions with nicotine and mecamylamine in rats: effects on memory function
Edward D Levin1, Ann Petro, Allison Beatty
1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. edlevin@duke.edu
Neurotoxicology and Teratology
|June 9, 2005
Summary
Olanzapine impaired working memory in schizophrenia patients. Nicotine treatment helped reverse these memory deficits, suggesting potential benefits for cognitive impairment in schizophrenia.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Schizophrenia involves cognitive impairment beyond psychosis.
- Traditional antipsychotics like haloperidol do not improve, and may worsen, cognitive deficits.
- Atypical antipsychotics, including olanzapine, may offer different cognitive effects due to varied receptor actions.
Purpose of the Study:
- To investigate the impact of olanzapine on working memory in schizophrenia.
- To assess the influence of nicotinic receptor interactions on olanzapine's cognitive effects, given high smoking rates in schizophrenia patients.
Main Methods:
- Working memory was measured using choice accuracy in a radial-arm maze.
- The study examined olanzapine's effects on this measure.
- Nicotine's modulatory effects on olanzapine-induced memory changes were evaluated.
Main Results:
- Olanzapine administration resulted in a significant impairment of working memory.
- Nicotine administration attenuated the working memory deficits induced by olanzapine.
Conclusions:
- Olanzapine can exacerbate working memory deficits in schizophrenia.
- Nicotinic co-treatment may be a viable strategy to mitigate cognitive impairment associated with schizophrenia.